MYELOMA MINUTE | Up To The Minute News | 8.20.2020 |
|
|
 |
Watch a Replay of the Latest IMF Patient & Family Webinar |
In case you missed it, watch a replay of this free two-hour IMF Patient & Family Webinar. Myeloma experts discussed the latest treatments for and management of myeloma, and IMF President and CEO Susie Durie presented a special feature on caregiving. The panel, moderated by IMF Chairman Dr. Brian G.M. Durie, included Dr. Joseph Mikhael of Translational Genomics Research Institute (TGen), Dr. Thomas Martin of the University of California San Francisco (UCSF) Health, and patient advocate Jack Aiello. |
|
 |
FDA Approves Kyprolis (carfilzomib) in Combination with Darzalex and Dexamethasone for Relapsed or Refractory Myeloma |
As IMF Chief Medical Officer Joseph Mikhael, MD, explains, "This is an important approval for myeloma patients. The combination uses two potent myeloma agents from separate classes together early in relapsed myeloma. As most patients relapse when on lenalidomide maintenance therapy, carfilzomib plus daratumumab can overcome lenalidomide resistance in a conveniently delivered and continuous manner to keep patients in remission. The two dosing strategies of weekly, or twice-weekly carfilzomib, allow for flexibility for patients." |
|
 |
Raise Funds for the Myeloma Community with This Simple Campaign |
MYELOMA 2020 — CLOSER TO A CURE is a simple letter-writing campaign to raise funds for the myeloma community. The IMF will provide you with the email/letter template that you can personalize with a link to your direct fund. If you're doing a mailing, we can send you self-addressed donation envelopes to include with your letter. With your help, we can reach our goal of raising $200,000. |
|
 |
And This Too Shall Pass…. |
Once again, the IMF is hosting a raffle for a 10-day stay at the Villa Ono Oasis in historic Kailua-Kona, Hawaii. While many of us have been affected by COVID-19, we hope to remind you that this too shall pass. If you purchase the winning $50 raffle ticket, you could find yourself just minutes from the Hawaiian coastline. Note: Bookings will be in the future based on mutual availability with you and the property owner. |
|
 |
IMF Offers CNE-Credit Symposium Opportunity |
As part of the Oncology Nursing Society's Bridge Virtual 2020 Event, the International Myeloma Foundation will provide a virtual symposium on September 8, 2020, at 2 p.m. PT / 5 p.m. ET. Learn more about Certified Nurse Educator (CNE) credits available and early access options. |
|
 |
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series |
This Week’s Question:
COVID-19 FAQ #21: How should myeloma patients conduct their follow-up appointments? |
|
|
|
|
We Thank Our Sponsors:
|
Amgen; Bristol-Myers Squibb; Genentech; GSK; Oncopeptides, Inc.; Sanofi-Genzyme; and Takeda Oncology |
We also thank individuals like you for your continued support! |
|
Join the conversation at The International Myeloma Foundation |
Facebook: /Myeloma | Twitter @IMFMyeloma | Instagram @IMFmyeloma
www.myeloma.org |
This email was sent by: The International Myeloma Foundation 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607-3421 Connect with the IMF InfoLine 1-800-452-2873 |
We respect your privacy and your preferences for communications of this nature. Home • Unsubscribe • Privacy Policy |
View as web page |